Chlorhexidine Disk for Prevention of Exit-site Infection in Peritoneal Dialysis Patients
- Conditions
- Peritoneal Dialysis Catheter Exit Site Infection
- Interventions
- Device: Chlorhexidine-impregnated disk
- Registration Number
- NCT03406520
- Lead Sponsor
- Singapore General Hospital
- Brief Summary
The purpose of the study is to evaluate the efficacy and safety of chlorhexidine-impregnated disk in preventing catheter exit-site infection in peritoneal dialysis patients
- Detailed Description
The primary aim of the study is to examine the exit-site infection rate in patients using chlorhexidine-impregnated dressing.
The participant will be followed up at 2, 6, 12, 24, 36 and 52 weeks of study and during each visit the catheter exit-site will be examined by one of the investigators for any sign of infection or allergic reaction, and questionnaires about satisfaction with use of study material (biopatch) will be asked by a study team member at the 12 week visit of the study. Each participant will be followed up for one year.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
- All adult incident peritoneal dialysis patients between 21 to 90 years old, who are followed up in Singapore General Hospital
- patients who have known history of allergy to chlorhexidine
- patients who had previous history of peritoneal dialysis catheter exit-site infection
- patients with mentally challenging conditions who are unable to give the valid consent for the study
- patients who have been involved in another study for exit site infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Chlorhexidine-impregnated disk Chlorhexidine-impregnated disk The chlorhexidine-impregnated disk, will be applied to the peritoneal dialysis catheter exit-site and the disk will be changed once a week
- Primary Outcome Measures
Name Time Method Exit-site/tunnel infection rate one year Exit-site/tunnel infection rate (reported as episodes per patient-year) in patients receiving chlorhexidine-impregnated disk
- Secondary Outcome Measures
Name Time Method Time to the first episode of exit-site/tunnel infection one year days from peritoneal dialysis initiation to the time develops first exit-site/tunnel infection
time to first episode of peritonitis one year days from peritoneal dialysis initiation to the time develops first episode of peritonitis
Peritoneal dialysis infection-related hospitalization one year Hospitalization due to peritoneal dialysis-related infection
comparison of the above outcomes with historical cohort using topical antibiotics cream one year comparison of exit-site/tunnel infection rate, peritonitis rate, time to first episode of exit-site/tunnel infection or peritonitis, technique failure rate, hospitalization rate, adverse events, mortality with historical cohort patients using topical gentamicin cream
adverse events one year any local or systemic adverse events
mortality one year all-cause mortality
patient satisfaction with the use of chlorhexidine-impregnated sponge dressing third month of study Questionnaires related to the treatment with chlorhexidine-impregnated disk
peritonitis rate one year Peritonitis rate (reported as episodes per patient-year) in patients receiving chlorhexidine-impregnated disk
technique failure rate one year technique failure is defined as transfer to hemodialysis for \>= 30 days
Trial Locations
- Locations (1)
Singapore General Hospital
🇸🇬Singapore, Singapore